Dr. Mark Paul Caruso, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 713 Broadway St Ste 203, Paintsville, KY 41240 Phone: 606-789-4949 Fax: 606-789-7690 |
Loey J Kousa, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 538 Main Street, Paintsville, KY 41240 Phone: 606-789-6086 Fax: 606-789-3811 |
News Archive
Adding a direct acting anti-viral drug to the standard treatment regimen for hepatitis C significantly increases the cure rate in the most difficult to treat patients, according to a research report published Monday in the online edition of the journal The Lancet.The research team, led by Paul Kwo, M.D., of Indiana University School of Medicine, reported that adding the drug nearly doubled the treatment's effectiveness when given for 48 weeks in one treatment arm of the study.
People with migraine are more likely to experience exacerbated skin sensitivity or pain after non-painful daily activities such as rubbing one's head, combing one's hair and wearing necklaces or earrings, compared to people with other types of headache, according to a study published in the April 22, 2008, issue of Neurology, the medical journal of the American Academy of Neurology.
Even people with blood pressure that is slightly above normal may be at an increased risk of stroke, according to a review of studies published in the September 28, 2011, online issue of Neurology, the medical journal of the American Academy of Neurology.
An analysis of US data from 2011 indicates that nearly 29 percent of cancer survivors are financially burdened as a result of their cancer diagnosis and/or treatment. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study also reveals that such hardships can have lasting physical and mental effects on cancer survivors.
Batten disease is a rare, fatal genetic disorder that affects children. Currently, no effective treatment exists for the disease, which ultimately kills all who are affected. Dachshunds also suffer from Batten disease, and now researchers from the University of Missouri College of Veterinary Medicine and School of Medicine, in collaboration with BioMarin Pharmaceutical Inc., have developed a treatment for the disease that has significantly delayed the onset and progression of symptoms in the Dachshunds.
› Verified 5 days ago